Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
Jiarui Li(First Affiliated Hospital Zhejiang University), Fengchao Zhao(First Affiliated Hospital Zhejiang University)
Cited by 11
Related Papers
MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL‐Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway
|Oxidative Medicine and Cellular Longevity|2022|11